Final 5-Year Study Results of DASISION: The Dasatinib Versus Imatinib Study in Treatment-Naïve Chronic Myeloid Leukemia Patients Trial von Cortes, Jorge E, Saglio, Giuseppe, Kantarjian, Hagop M, Baccarani, Michele, Mayer, Jiří, Boqué, Concepción, Shah, Neil P, Chuah, Charles, Casanova, Luis, Bradley-Garelik, Brigid, Manos, George, Hochhaus, Andreas

Volltext

Bosutinib Versus Imatinib for Newly Diagnosed Chronic Myeloid Leukemia: Results From the Randomized BFORE Trial von Cortes, Jorge E, Gambacorti-Passerini, Carlo, Deininger, Michael W, Mauro, Michael J, Chuah, Charles, Kim, Dong-Wook, Dyagil, Irina, Glushko, Nataliia, Milojkovic, Dragana, le Coutre, Philipp, Garcia-Gutierrez, Valentin, Reilly, Laurence, Jeynes-Ellis, Allison, Leip, Eric, Bardy-Bouxin, Nathalie, Hochhaus, Andreas, Brümmendorf, Tim H

Volltext

Chronic myeloid leukaemia von Hehlmann, Rüdiger, Prof, Hochhaus, Andreas, Prof, Baccarani, Michele, Prof

Volltext

Clinical, social, and psycho-oncological needs of adolescents and young adults (AYA) versus older patients following hematopoietic stem cell transplantation von Pulewka, Kristin, Strauss, Bernhard, Hochhaus, Andreas, Hilgendorf, Inken

Volltext

Dasatinib versus Imatinib in Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia von Kantarjian, Hagop, Shah, Neil P, Shah, Sandip, Hochhaus, Andreas, Cortes, Jorge, Ayala, Manuel, Moiraghi, Beatriz, Shen, Zhixiang, Mayer, Jiri, Pasquini, Ricardo, Nakamae, Hirohisa, Huguet, Françoise, Boqué, Concepción, Chuah, Charles, Bleickardt, Eric, Bradley-Garelik, M. Brigid, Zhu, Chao, Szatrowski, Ted, Shapiro, David, Baccarani, Michele

Volltext

Low BCR-ABL expression levels in hematopoietic precursor cells enable persistence of chronic myeloid leukemia under imatinib von Kumari, Ashu, Brendel, Cornelia, Hochhaus, Andreas, Neubauer, Andreas, Burchert, Andreas

Volltext

Inactivating mutations of the histone methyltransferase gene EZH2 in myeloid disorders von Cross, Nicholas C P, Ernst, Thomas, Chase, Andrew J, Score, Joannah, Hidalgo-Curtis, Claire E, Bryant, Catherine, Jones, Amy V, Waghorn, Katherine, Zoi, Katerina, Ross, Fiona M, Reiter, Andreas, Hochhaus, Andreas, Drexler, Hans G, Duncombe, Andrew, Cervantes, Francisco, Oscier, David, Boultwood, Jacqueline, Grand, Francis H

Volltext

Dasatinib in imatinib‐resistant or ‐intolerant chronic‐phase, chronic myeloid leukemia patients: 7‐year follow‐up of study CA180‐034 von Shah, Neil P., Rousselot, Philippe, Schiffer, Charles, Rea, Delphine, Cortes, Jorge E., Milone, Jorge, Mohamed, Hesham, Healey, Diane, Kantarjian, Hagop, Hochhaus, Andreas, Saglio, Giuseppe

Volltext

Front-Line and Salvage Therapies With Tyrosine Kinase Inhibitors and Other Treatments in Chronic Myeloid Leukemia von Cortes, Jorge, Hochhaus, Andreas, Hughes, Timothy, Kantarjian, Hagop

Volltext

Laying the foundation for genomically-based risk assessment in chronic myeloid leukemia von Branford, Susan, Kim, Dennis Dong Hwan, Apperley, Jane F., Eide, Christopher A., Mustjoki, Satu, Ong, S. Tiong, Nteliopoulos, Georgios, Ernst, Thomas, Chuah, Charles, Gambacorti-Passerini, Carlo, Mauro, Michael J., Druker, Brian J., Kim, Dong-Wook, Mahon, Francois-Xavier, Cortes, Jorge, Radich, Jerry P., Hochhaus, Andreas, Hughes, Timothy P.

Volltext

Hemophagocytic lymphohistiocytosis in adults: collaborative analysis of 137 cases of a nationwide German registry von Birndt, Sebastian, Schenk, Thomas, Heinevetter, Babett, Brunkhorst, Frank M., Maschmeyer, Georg, Rothmann, Frank, Weber, Thomas, Müller, Markus, Panse, Jens, Penack, Olaf, Schroers, Roland, Braess, Jan, Frickhofen, Norbert, Ehl, Stephan, Janka, Gritta, Lehmberg, Kai, Pletz, Mathias W., Hochhaus, Andreas, Ernst, Thomas, La Rosée, Paul

Volltext

Chemoradiotherapy with capecitabine versus fluorouracil for locally advanced rectal cancer: a randomised, multicentre, non-inferiority, phase 3 trial von Hofheinz, Ralf-Dieter, Prof, Wenz, Frederik, Prof, Post, Stefan, Prof, Matzdorff, Axel, Prof, Laechelt, Stephan, MD, Hartmann, Jörg T, Prof, Müller, Lothar, MD, Link, Hartmut, Prof, Moehler, Markus, Prof, Kettner, Erika, MD, Fritz, Elisabeth, MD, Hieber, Udo, MD, Lindemann, Hans Walter, MD, Grunewald, Martina, MD, Kremers, Stephan, MD, Constantin, Christian, MD, Hipp, Matthias, MD, Hartung, Gernot, Prof, Gencer, Deniz, MD, Kienle, Peter, Prof, Burkholder, Iris, PhD, Hochhaus, Andreas, Prof

Volltext

SIRT7: an influence factor in healthy aging and the development of age-dependent myeloid stem-cell disorders von Kaiser, Alexander, Schmidt, Martin, Huber, Otmar, Frietsch, Jochen J., Scholl, Sebastian, Heidel, Florian H., Hochhaus, Andreas, Müller, Jörg P., Ernst, Thomas

Volltext

µPhos: a scalable and sensitive platform for high-dimensional phosphoproteomics von Oliinyk, Denys, Will, Andreas, Schneidmadel, Felix R, Böhme, Maximilian, Rinke, Jenny, Hochhaus, Andreas, Ernst, Thomas, Hahn, Nina, Geis, Christian, Lubeck, Markus, Raether, Oliver, Humphrey, Sean J, Meier, Florian

Volltext

Expression of the miR-17-92 polycistron in chronic myeloid leukemia (CML) CD34+ cells von Venturini, Letizia, Battmer, Karin, Castoldi, Mirco, Schultheis, Beate, Hochhaus, Andreas, Muckenthaler, Martina U., Ganser, Arnold, Eder, Matthias, Scherr, Michaela

Volltext

Tolerability-Adapted Imatinib 800 mg/d Versus 400 mg/d Versus 400 mg/d Plus Interferon-α in Newly Diagnosed Chronic Myeloid Leukemia von Rüdiger Hehlmann, Michael Lauseker, Susanne Jung-Munkwitz, Armin Leitner, Martin C. Müller, Nadine Pletsch, Ulrike Proetel, Claudia Haferlach, Brigitte Schlegelberger, Leopold Balleisen, Mathias Hänel, Markus Pfirrmann, Stefan W. Krause, Christoph Nerl, Hans Pralle, Alois Gratwohl, Dieter K. Hossfeld, Joerg Hasford, Andreas Hochhaus, Susanne Saußele

Volltext

Sustained Molecular Response With Interferon Alfa Maintenance After Induction Therapy With Imatinib Plus Interferon Alfa in Patients With Chronic Myeloid Leukemia von BURCHERT, Andreas, MÜLLER, Martin C, KOSTREWA, Philippe, ERBEN, Philipp, BOSTEL, Tilman, LIEBLER, Simone, HEHLMANN, Rüdiger, NEUBAUER, Andreas, HOCHHAUS, Andreas

Volltext

Dasatinib treatment of chronic-phase chronic myeloid leukemia: analysis of responses according to preexisting BCR-ABL mutations von Müller, Martin C., Cortes, Jorge E., Kim, Dong-Wook, Druker, Brian J., Erben, Philipp, Pasquini, Ricardo, Branford, Susan, Hughes, Timothy P., Radich, Jerald P., Ploughman, Lynn, Mukhopadhyay, Jaydip, Hochhaus, Andreas

Volltext

Nilotinib in Imatinib-Resistant CML and Philadelphia Chromosome–Positive ALL von Kantarjian, Hagop, Giles, Francis, Wunderle, Lydia, Bhalla, Kapil, O'Brien, Susan, Wassmann, Barbara, Tanaka, Chiaki, Manley, Paul, Rae, Patricia, Mietlowski, William, Bochinski, Kathy, Hochhaus, Andreas, Griffin, James D, Hoelzer, Dieter, Albitar, Maher, Dugan, Margaret, Cortes, Jorge, Alland, Leila, Ottmann, Oliver G

Volltext

Targeting the phosphoinositide 3-kinase pathway in hematologic malignancies von Jabbour, Elias, Ottmann, Oliver G, Deininger, Michael, Hochhaus, Andreas

Volltext